Peptide therapy reports positive Phase I results in Parkinson's disease
BioXconomy reports early-stage success for an experimental peptide candidate in Parkinson's patients.
PR
By Priya Raman · Science Reporter
Sep 16 05:29 ETSource: BioXconomy
The wire
- 01A peptide therapy was reported to succeed in Phase I Parkinson's disease trials.
- 02Early safety signals could support advancement of peptide approaches in neurodegeneration.
- 03Developer name, dosing and efficacy endpoints were not specified in the excerpt.
From the source
Read at news.google.comPeptide therapy triumphs in Phase I Parkinson’s trials